Literature DB >> 9200875

Neonatal insulin secretion: implications for the programming of metabolic homeostasis.

A Aynsley-Green1, J M Hawdon, S Deshpande, M W Platt, K Lindley, A Lucas.   

Abstract

Patterns of metabolic adaptation are described in the neonate, which generate two fundamental concepts. First, that early nutritional experiences may have long-term effects on the control of metabolic homeostasis, and second, that insulin has a fundamental role in this process. The endocrine pancreas in the neonate is unable to regulate insulin secretion in relation to blood glucose concentration with the same level of tight control seen in the older child and adult. Moreover, the pattern of metabolic adaptation in the fullterm infant in the first postnatal week is different to that of the preterm baby and the infant born small-for-gestational-age (SGA), with both preterm and SGA infants being unable to generate counter-regulatory ketogenesis as blood glucose concentrations fall. The inability to initiate ketogenesis and switch off insulin secretion after birth persists for several weeks in preterm infants. Methods of feeding term and preterm infants have profound effects on the neonatal endocrine milieu and it is suggested that patterns of insulin secretion provoked in the newborn period may 'programme' the subsequent development of metabolic control. The recently described molecular mechanisms that underlie the pathogenesis of abnormal insulin secretion in the syndrome of persistent hyperinsulinaemic hypoglycemia of infancy (or pancreatic nesidioblastosis) may offer insights into how such programming may occur.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9200875

Source DB:  PubMed          Journal:  Acta Paediatr Jpn        ISSN: 0374-5600


  4 in total

Review 1.  Does continuous insulin infusion improve glycaemic control and nutrition in hyperglycaemic very low birth weight infants?

Authors:  V Kairamkonda
Journal:  Arch Dis Child       Date:  2006-01       Impact factor: 3.791

2.  A randomised controlled trial of early insulin therapy in very low birth weight infants, "NIRTURE" (neonatal insulin replacement therapy in Europe).

Authors:  Kathryn Beardsall; Sophie Vanhaesebrouck; Amanda L Ogilvy-Stuart; Jag S Ahluwalia; Christine Vanhole; Christopher Palmer; Paula Midgley; Mike Thompson; Luc Cornette; Mirjam Weissenbruch; Marta Thio; Francis de Zegher; David Dunger
Journal:  BMC Pediatr       Date:  2007-08-10       Impact factor: 2.125

3.  Neonatal treatment with scopolamine butylbromide prevents metabolic dysfunction in male rats.

Authors:  Ananda Malta; Aline Amenencia de Souza; Tatiane Aparecida Ribeiro; Flávio Andrade Francisco; Audrei Pavanello; Kelly Valério Prates; Laize Peron Tófolo; Rosiane Aparecida Miranda; Júlio Cezar de Oliveira; Isabela Peixoto Martins; Carina Previate; Rodrigo Mello Gomes; Claudinéia Conationi da Silva Franco; Maria Raquel Marçal Natali; Kesia Palma-Rigo; Paulo Cezar de Freitas Mathias
Journal:  Sci Rep       Date:  2016-08-26       Impact factor: 4.379

4.  Insulin and glucose responses to hypoxia in male and female neonatal rats: Effects of the androgen receptor antagonist flutamide.

Authors:  Santiago Rolon; Christine Huynh; Maya Guenther; Minhal Gardezi; Jonathan Phillips; Ashley L Gehrand; Hershel Raff
Journal:  Physiol Rep       Date:  2021-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.